Global Retirement Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Global Retirement Partners’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$4.25K	Buy	+103	New	+$4.13K	﹤0.01%	3487

Other funds holding KNSA

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Global Retirement Partners's KNSA Position: Q4 2025 in Review

Global Retirement Partners opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q4 2025: 103 shares worth $4.25K. The stake represents ﹤0.01% of the portfolio and ranks #3487 among its holdings.

224 funds tracked by Wall St. Rank hold KNSA as of Q4 2025.

Global Retirement Partners held 103 shares of Kiniksa Pharmaceuticals worth $4.25K as of Q4 2025.
Kiniksa Pharmaceuticals was a new Global Retirement Partners position in Q4 2025.
Kiniksa Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3487 holding.
224 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.